News

Archives: Search / 2017 / 2016 / 2015 / 2014 / 2013 / 2012

2015 Archives

Oct 29, 2015
Conference Call and Webcast Scheduled for November 6, 2015 at 8:30 a.m. ET
Aug 6, 2015
Pipeline continues to mature towards objective of six products being marketed in 2016
Jul 27, 2015
Provides additional details on AT-002 in dogs
Jul 21, 2015
Conference Call and Webcast scheduled for August 7, 2015, 8:30 a.m. ET
Jul 14, 2015
Commercialization anticipated in 2016
Jun 26, 2015
Commercialization Anticipated in 2016
May 14, 2015
Veterinary Industry Thought Leaders and Members of Aratana to Highlight Advances in the Treatment of Oncology, Inappetence and Pain for Pets
May 7, 2015
-- Announces full-enrollment of two pivotal field effectiveness studies --
May 4, 2015
Traverse Biosciences Also Grants Aratana Therapeutics the Exclusive Option to Sublicense TRB-N0224
May 1, 2015
Conference Call and Webcast scheduled for May 8, 2015, 8:30 a.m. ET
Apr 27, 2015
ADXS31-164 (AT-014) in Combination with Palliative Radiation Delays Tumor Progression, Prolongs Overall Survival and Maintains Limb Function in Preliminary Data from a Clinical Study in Canine Osteosarcoma
 
print email rss